SCHEMBL7602706

SCHEMBL7602706

CC(Oc1ccc(CC(=O)c2ccccc2)cc1)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.50
PPARA Q07869 1/20 0.50
PLAU P00749 1/20 0.47
STS P08842 1/20 0.46
POLB P06746 1/20 0.45
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CNR2 P34972 1/20 0.43
ALOX5 P09917 1/20 0.43
NPY5R Q15761 1/20 0.42
SRD5A2 P31213 2/20 0.42
FFAR1 O14842 1/20 0.42
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7602308 0.94 PPARG (0.56) PPARGPPARAPLAUSTSMAPT
SCHEMBL7598667 0.80 ELANE (0.57) STSSRD5A2ALDH1A1GAARAB9A
SCHEMBL6784674 0.78 PLAU (0.48) PPARGPPARAPLAUSTSUSP2
SCHEMBL7598201 0.77 ABCB1 (0.50) TP53MAPTL3MBTL1ALDH1A1GAA
SCHEMBL571063 0.77 USP2 (0.69) PLAUSTSPOLBUSP2TP53
SCHEMBL9541930 0.76 SRD5A2 (0.62) PPARGPPARAPLAUSTSUSP2
Isobutane SCHEMBL1801676 0.76 MAPT (0.63) PPARGPPARAPLAUSTSMAPT
SCHEMBL7597047 0.76 ESR1 (0.47) PPARGPPARATP53MAPTCNR2
SCHEMBL7597060 0.76 ESR1 (0.47) PPARGPPARATP53MAPTCNR2
SCHEMBL7199268 0.76 MAPT (0.67) PLAUSTSMAPTL3MBTL1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG PPARG 115/4885PPARA 211/4885PLAU 2750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.